...
首页> 外文期刊>International Journal of Biological Macromolecules: Structure, Function and Interactions >In vivo and ex vivo EPR detection of spin-labelled ovalbumin in mice
【24h】

In vivo and ex vivo EPR detection of spin-labelled ovalbumin in mice

机译:体内和体外EPR检测小鼠中自旋标记的卵清蛋白

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, spin-labelled ovalbumin (SL-OVA), free or entrapped in liposomes, was administered to mice subcutaneously (s.c.) or intravenously (i.v.) with the aim to determine the conditions for pharmacokinetic studies of spin-labelled proteins by EPR and to measure the time course of SL-OVA distribution in vivo in live mice and ex vivo in isolated organs. Upon s.c. administration, the decay of the EPR signal was followed for 60min at the site of application using an L-band EPR spectrometer. Within this time period, the signal of free SL-OVA was diminished by about 70%. It was estimated with the help of the oxidizing agent K_3[(FeCN)_6] that approximately 30% was a consequence of the spin label reduction to EPR non-visible hydroxylamine and about 40% was due to the SL-OVA elimination from the site of measurement. For liposome encapsulated SL-OVA, the intensity diminished only by approx. 40% in the same period, indicating that liposomes successfully protect the protein from reduction. EPR signal could not be detected directly over live mouse organs within 60min after s.c. application of SL-OVA. With the available L-band EPR spectrometer, the measurements at the site of s.c. application are possible if the amount of SL-OVA applied to a mouse is more than 3mg. For the pharmacokinetic studies of the protein distribution in organs after s.c. or i.v. injection the concentration of the spin-labelled protein should be more than 0.5mmol/kg.After i.v. administration, only ex vivo measurements were possible using an X-band EPR spectrometer, since the total amount of SL-OVA was not sufficient for in vivo detection and also because of rapid reduction of nitroxide. After 2. min, the protein was preferentially distributed to liver and, to a smaller extent, to spleen.
机译:在这项研究中,将游离或包裹在脂质体中的自旋标记卵清蛋白(SL-OVA)皮下(sc)或静脉内(iv)给予小鼠,目的是确定通过EPR进行自旋标记蛋白的药代动力学研究的条件并测量活体小鼠体内SL-OVA分布的时程以及离体器官中离体的时间。在s.c.在给药过程中,使用L波段EPR光谱仪在应用部位跟踪EPR信号的衰减60分钟。在这段时间内,游离SL-OVA的信号减少了约70%。借助于氧化剂K_3 [(FeCN)_6]估计,大约30%是自旋标记还原为EPR不可见羟胺的结果,而大约40%是由于SL-OVA从该部位被消除测量。对于脂质体包封的SL-OVA,强度仅降低了约。同期有40%的脂质体,表明脂质体成功保护了蛋白质免于还原。在s.c.之后的60分钟内,无法直接在活的小鼠器官上检测到EPR信号。 SL-OVA的应用。使用可用的L波段EPR光谱仪,可在s.c现场进行测量。如果应用于小鼠的SL-OVA的量超过3mg,则可以应用。用于皮下注射后器官中蛋白质分布的药代动力学研究。或i.v.静脉注射后,自旋标记蛋白的浓度应大于0.5mmol / kg。由于SL-OVA的总量不足以进行体内检测,而且由于一氧化氮的快速还原,使用X波段EPR光谱仪只能进行离体测量。 2分钟后,蛋白质优先分配到肝脏,并在较小程度上分配到脾脏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号